Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials
BackgroundIn recent decades, tranexamic acid (TXA) antifibrinolytic therapy before aneurysm clipping or embolization has been widely reported, but its safety and efficacy remain controversial. This meta-analysis evaluated the efficacy and safety of TXA therapy in aneurysmal subarachnoid hemorrhage (...
Main Authors: | Junwei Ren, Dongxi Qian, Jiaming Wu, Lingyan Ni, Wei Qian, Guozheng Zhao, Chuanjun Huang, Xing Liu, Yu Zou, Weikang Xing |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.710495/full |
Similar Items
-
Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Min Shi, et al.
Published: (2022-01-01) -
Biomarkers in aneurysmal subarachnoid hemorrhage: A short review
by: Sávio Batista, et al.
Published: (2023-07-01) -
Several Risk Factors for Aneurysmal Subarachnoid Hemorrhage
by: Pavel G. Shnyakin, et al.
Published: (2023-06-01) -
Pituitary deficiency after aneurysmal subarachnoid hemorrhage
by: Julio Leonardo Barbosa Pereira, et al.
Published: (2013-06-01) -
Updates on aneurysmal subarachnoid hemorrhage: is there anything really new?
by: Thire Baggio Machado Marazzi, et al.
Published: (2022-08-01)